International Biotechnology Trust (IBT)
Category Sector Equity Biotechnology
This investment trust can be held in an Investment ISA, SIPP and Investment Account
Some Investment Trusts include direct costs as part of their Ongoing charge, such as the annual management charge. For those that show Ongoing charges as 0% please review the investment literature for details on the charges that will apply. The Financial Conduct Authority will review this in 2025.
If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice.
If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice.
Sell
710.00p
Buy
716.00p
6.00p (+0.85%)
Discount/Premium
-9.57%
Estimated NAV
791.744p
Prices updated at 24 Jan 2025, 16:45 GMT
| Prices minimum 15 mins delay
Prices in GBX
Investment objective
The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies. The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with suitably experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology.
Important documents: Please ensure that you have read the Key Information Document/Technical Guide
, Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.
- Key stats
- Price
- Performance
- Charges & documents
- Shares & trades
- Dividends
- Portfolio
- Risk
- News & dates
- Trust info
- Director info
Portfolio as of 31/12/2024
Asset allocation
Show long & short position
Geographical breakdown
Continent or country allocation (%)
Market classification (%)
Top 10 holdings
1
Scb Sholo211123b 27-Sep-2024 5.98% 28-Oct-2024
Sector
-
Country
-
% of assets
8.35912
2
Vera Therapeutics Inc Class A
Sector
-
Country
United States
% of assets
5.87109
3
Intra-Cellular Therapies Inc
Sector
-
Country
United States
% of assets
5.12698
4
Supernus Pharmaceuticals Inc
Sector
-
Country
United States
% of assets
4.45618
5
Regeneron Pharmaceuticals Inc
Sector
-
Country
United States
% of assets
3.6464
6
Sv Fund Vi Investment
Sector
-
Country
-
% of assets
3.60048
7
Sv Bcof
Sector
-
Country
-
% of assets
3.5621
8
Ascendis Pharma AS ADR
Sector
-
Country
Denmark
% of assets
3.36242
9
Insmed Inc
Sector
-
Country
United States
% of assets
2.85469
10
Neurocrine Biosciences Inc
Sector
-
Country
United States
% of assets
2.81813
Assets in top 10 holdings %
43.66%
Total no. of equity holdings
82.00
Total no. of bond holdings
-
Stock sectors
International Biotechnology Trust
Sector Equity Biotechnology
0.00%
Basic materials
Con cyclical
Financial svs
Real estate
0.00%
Comm services
Energy
Industrials
Technology
100.00%
Con defensive
Healthcare
Utilities